home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Treatment-Resistant Depression Might Be In The Genes

  February, 21 2008 9:57
your information resource in human molecular genetics

Variation in the gene coding for the potassium channel TREK1 may explain why some patients with depression do not respond to commonly prescribed antidepressants. If confirmed, this finding, reported online this week in the journal Neuropsychopharmacology, could lead to better ways of identifying and treating patients unlikely to benefit from conventional drug regimens.

Roy Perlis and colleagues studied the genes of patients who did not respond to an initial trial of selective serotonin reuptake inhibitors (SSRIs). Of these patients, they found that those with a common variation in the gene for TREK1, often failed to respond to one or two subsequent treatments. SSRIs are known to inhibit TREK1 and mice lacking this channel are resistant to depression. These results suggest TREK1 could regulate one?s response to antidepressants.

While further research is necessary to determine how these variations interfere with treatment, this study is one of the first to examine the genetic underpinnings of treatment resistant depression, a prevalent and costly disease with a poor prognosis.

Author contact:

Roy Perlis (Massachusetts General Hospital, Boston, MA, USA)
E-mail: rperlis@partners.org

(C) Neuropsychopharmacology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.